Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (1137)	9/8/1998 11:02:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 10280

Mazen, I'm still around, still very much very long SEPR, although I did cash in the calls I bought the last time the stock collapsed for no reason. I haven't been posting recently because there really hasn't been much in the way of SEPR-specific news. The stock has been tossed around by the general market chaos, but by and large has held up nicely. I think the SEPR play still has a few years to go, and that the best policy is to try hard to ignore the short-term ups and downs. SEPR seems to be a pretty tight company, with not much movement before significant announcements. The occasional sharp drops in the stock price have (to date) not proved to be harbingers of bad news. I'm going to continue my (so far) successful policy of buying a few calls whenever we get one of these unexplained drops. A nice recovery by the biotechs today. Maybe people have finally figured out that there isn't another sector that is more remote from foreign troubles. I'd stay with the more liquid biotechs for now, although there are starting to be some compelling values in the third tier stocks. Peter